Adoptive Cellular Therapy 2025 & Beyond

In support of improving patient care, Duke University Health System Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team. The designation was based upon the quality of the educational activity and its compliance with the standards and policies of the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC).

 

image

 

Program Description: Once monthly 1 CME credit hour events directed toward advanced practice providers as well as pharmacists and registered nurses who care for all patients treated at Duke Cancer Institute.

Target Audience

Nurses

Nurse Practitioners

Physicians

Physician Assistants

Pharmacists

Learning Objectives

  1. Understanding the upcoming advancements in CAR T for lymphoid malignancies and their advantages to the current standard of care.
  2. Understanding the new cellular therapy products being investigated for solid tumors and their expected toxicities.
Course summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
Registration Opens: 
11/04/2025
Registration Expires: 
11/04/2027
Part of: 
DCI-Advanced Practice Provider Lecture Series 2025 Enduring
Rating: 
0

Chenyu Lin, MD (Financial Relationships to disclose below)

Autolus Therapeutics- Advisory Board

ADC Therapeutics- Advisory Board

ACPE - Pharmacist

AMA PRA Category 1 Credit(s)

ANCC

Attendance

JA Credit - AH

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
Please login or register to take this course.